Medical Knowledge Group

What Medical Knowledge Group does

Medical Knowledge Group (MKG) is a privately held, New York-based strategic commercialization partner to biopharma innovators. Founded in 2004 and organized as Medical Knowledge Group, LLC, the firm operates through 13–14 wholly-owned specialized business units (81qd, Envision, ESquared Communications, Flince, HLX, Magnolia Innovation, Magnolia Market Access, MEI Solutions, Resonant, Sound, SciMed, SPHASE, Synapse, Vereo) that collectively deliver medical communications, brand strategy consulting, market research, market access strategy, brand advertising, and advanced network-mapping and patient-finding analytics. MKG employs 650+ professionals and serves biopharma decision-makers across clinical, commercial, and market access teams from early development through brand maturity.

The company's underlying technology positioning is an AI- and analytics-driven drug commercialization platform that combines proprietary data solutions with deep therapeutic expertise. Stated technical differentiators include AI and machine learning applied to drug commercialization decisions, proprietary data assets, and network-mapping and patient-finding analytics used to identify stakeholders and decision-makers. The firm markets an integrated offering that aligns strategy, messaging, engagement, and activation across the product lifecycle, and a March 2026 board appointment of an AI product leader from Google and Waymo signals an intent to deepen internal AI capability.

MKG's business model is professional services sold directly to enterprise biopharma clients through a field sales and strategic advisory motion. The portfolio of subsidiaries enables cross-selling of medcomms, analytics, market access, and brand services within a single biopharma account. Pricing is not publicly disclosed and is structured around integrated engagements. The firm has been backed by multiple healthcare-focused private equity investors (CIVC Partners in 2008, WindRose Health Investors in 2017 and 2020, Aisling Capital in 2019, and Novo Holdings in 2022) and has executed at least one disclosed acquisition (Conisus, July 2021), consistent with a platform roll-up strategy.

Name

Medical Knowledge Group

Legal name

Medical Knowledge Group, LLC

Website

https://mkgny.com

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

51–100 employees

Short description

Medical Knowledge Group is a privately held biopharma commercialization partner that operates 13–14 specialized subsidiaries delivering medical communications, brand strategy, market access, and AI-enabled analytics to enterprise biopharma clients across the product lifecycle.

Ownership category

akta.pro rank

Product category

Biopharma Commercialization Services

NAICS

Management Consulting Services (54161), Other Management Consulting Services (541618)

SIC

Services-Management Consulting Services (8742)

akta.pro primary industry

Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D) (HLAGAJAF)

Keywords

• Medical communications
• Biopharma commercialization
• Market access consulting
• Healthcare data analytics
• Brand strategy consulting

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Revenue model

1. Professional Services - Biopharma: MKG provides integrated solutions in medical communications, brand strategy consulting, market research, market access strategy, and brand advertising to biopharma companies across the product lifecycle

Go-to-market motion2 records

Distribution channels2 records

Marketing channels3 records

Core offering

Medical Knowledge Group (MKG) is a strategic commercialization partner to biopharma innovators, providing integrated solutions across the product lifecycle. Through 13 specialized business units, MKG delivers medical communications, brand strategy consulting, advanced network-mapping and patient-finding analytics, market research, market access strategy, and brand advertising supported by proprietary data solutions and AI-enabled analytics. The company employs 650+ professionals and serves enterprise biopharma clients from early development through brand maturity.

Product overview

Medical Knowledge Group (MKG) is a strategic commercialization partner to biopharma innovators, operating as a multi-unit platform that provides integrated solutions across the product lifecycle. The portfolio consists of 14 subsidiary companies: 81qd, Envision, ESquared Communications, Flince, HLX, Magnolia Innovation, Magnolia Market Access, MEI Solutions, Resonant, Sound, Scimed, SPHASE, Synapse, and Vereo. These subsidiaries collectively deliver integrated services including medical communications, brand strategy consulting, advanced network-mapping and patient-finding analytics, market research, market access strategy, and brand advertising, supported by proprietary data solutions and AI-enabled analytics. The organization employs over 650 professionals across 13 business units, partnering with biopharma decision-makers from early development through brand maturity.

Differentiator

Problem solved

Functional benefit

Products and services

• 81qd One of MKG's network companies providing specialized biopharma commercialization services.
• Envision Strategic communications and consulting services for biopharma brands.
• ESquared Communications Medical and scientific communications agency within the MKG network.
• Flince Research and analytics services provider.
• HLX Healthcare communications and marketing services.
• Magnolia Innovation Market access and innovation services for biopharma products.
• Magnolia Market Access Specialized market access strategy services.
• MEI Solutions Medical education and information solutions provider.
• Resonant Healthcare communications services.
• Sound Healthcare Communications Healthcare communications and engagement services.
• SciMed Scientific and medical communications services.
• SPHASE Phase-specific commercialization services.
• Synapse Strategic healthcare communications.
• Vereo Communications Healthcare communications and engagement solutions.

Named customers1 record

Segments4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

14 partnerships are on record, tiered core.

• 81qdcoreOthers81qd is part of the MKG network of companies, providing specialized services within the integrated portfolio of MKG business units focused on biopharma commercialization.
• EnvisioncoreOthersEnvision is part of the MKG network of companies, operating as a specialized business unit within the integrated MKG portfolio.
• ESquared CommunicationscoreOthersESquared Communications is part of the MKG network of companies, providing specialized communications services within the MKG portfolio.
• FlincecoreOthersFlince is part of the MKG network of companies, offering specialized research services within the MKG business unit portfolio.
• HLXcoreOthersHLX is part of the MKG network of companies, operating as a specialized business unit within the integrated MKG portfolio.
• Magnolia InnovationcoreOthersMagnolia Innovation is part of the MKG network of companies, providing specialized innovation services within the MKG portfolio.
• Magnolia Market AccesscoreOthersMagnolia Market Access is part of the MKG network of companies, focusing on market access strategy within the MKG portfolio.
• MEI SolutionscoreOthersMEI Solutions is part of the MKG network of companies, providing specialized solutions within the MKG business unit portfolio.
• ResonantcoreOthersResonant is part of the MKG network of companies, operating as a specialized healthcare communications business unit.
• Sound Healthcare CommunicationscoreOthersSound Healthcare Communications is part of the MKG network of companies, providing specialized healthcare communications services.
• SciMedcoreOthersSciMed is part of the MKG network of companies, providing specialized scientific and medical communications services.
• SPHASEcoreOthersSPHASE is part of the MKG network of companies, operating as a specialized business unit within the integrated MKG portfolio.
• SynapsecoreOthersSynapse is part of the MKG network of companies, providing specialized services within the MKG business unit portfolio.
• Vereo CommunicationscoreOthersVereo Communications is part of the MKG network of companies, providing specialized communications services within the MKG portfolio.

Scale indicators2 records

Recent moves6 records

Expansion highlights4 records

Market position

Competitive moat5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/medical-knowledge-group

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries14 records

Funding overview

Funding rounds5 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medical Knowledge Group